StonvexLoading…
StonvexStonvexStonvexCore line items from ETD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $432.74M | $296.90M | $146.98M | $614.65M |
Operating Income | $30.67M | $24.20M | $9.97M | $61.99M |
Net Income | $28.13M | $11.74M | $10.45M | $51.60M |
EPS (Diluted) | $1.10 | $0.87 | $0.41 | $2.01 |
Total Assets | $723.26M | $714.77M | $737.11M | $737.10M |
Total Liabilities | $249.52M | $236.68M | $261.72M | $254.83M |
Cash & Equivalents | $66.57M | $64.27M | $73.65M | $76.18M |
Free Cash Flow OCF − CapEx | $21.80M | $9.71M | $14.43M | $50.43M |
Shares Outstanding | 25.45M | 25.45M | 25.45M | 25.43M |